Company · CIK 0001836056
Ambrx Biopharma Cayman, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Cayman Islands
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AAmbrx Biopharma Cayman, Inc.0001193125-24-030277 · 132.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-254549 · 553.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-253527 · 225.2 KBSEC(opens sec.gov)
- SC 13GAmbrx Biopharma Inc.0001140361-23-047537 · 53.6 KBSEC(opens sec.gov)
- 8-KCurrent report0000950170-23-052396 · 218.0 KBSEC(opens sec.gov)
- SC 13GAmbrx Biopharma Inc.0001104659-23-103570 · 77.8 KBSEC(opens sec.gov)
- 8-KCurrent report0000950170-23-049468 · 233.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-236202 · 270.7 KBSEC(opens sec.gov)
- 8-KCurrent report0000950170-23-046718 · 235.4 KBSEC(opens sec.gov)
- 8-KCurrent report0000950170-23-044643 · 236.6 KBSEC(opens sec.gov)
Insiders
- Aromando AndrewChief Operating Officer
- Chang XiaoweiDirector
- Chen Bihua10% Owner
- Commodore Capital LP10% Owner
- Cormorant Asset Management, LP10% Owner
- Cormorant Private Healthcare Fund III LP10% Owner
- DALESANDRO MARGARETDirector
- Darwin Global Management, Ltd.10% Owner
- Darwin Global Master Fund, Ltd.10% Owner
- Glover Stephen C.Director
Tickers
No tickers on record.
Addresses
business
10975 NORTH TORREY PINES ROAD
LA JOLLA, CA, 92037
mailing
10975 NORTH TORREY PINES ROAD
LA JOLLA, CA, 92037
Former names
- Ambrx Biopharma Inc.2023-10-10
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies